Browse > Article
http://dx.doi.org/10.3746/jfn.2006.11.3.204

Radical Scavenging and Antihypercholesterolemic Effects of Red Yeast Rice in Cholesterol Fed Rats  

Suh, Hyung-Joo (Department of Food and Nutrition, Korea University)
Kim, Young-Soon (Department of Food and Nutrition, Korea University)
Chang, Un-Jae (Department of Food and Nutrition, Dongduk Women's University)
Oh, Sung-Hoon (Department of Food and Biotechnology, Ansan College of Technology)
Bae, Song-Hwan (Department of Food and Biotechnology, Hankyong National University)
Publication Information
Preventive Nutrition and Food Science / v.11, no.3, 2006 , pp. 204-209 More about this Journal
Abstract
This study demonstrates that red yeast rice exhibits radical scavenging and antihypercholesterolemic activities in rats fed cholesterol. Sprague-Dawley male rats were divided to five dietary groups (normal, chol-control; and M-1, M-2 & M-3 administered 150, 300, and 500 mg/kg red yeast rice, respectively) and fed their respective diets for 4 weeks. No significant differences in food efficiency ratio (FER) were found among the five groups. The weight of perirenal fat pads decreased with increasing amounts of red yeast rice supplementation. There was a significant decrease in the levels of cholesterol in M-3 group fed red yeast rice with 500 mg/kg compared to those in the chol-control, M-1 and M-2 groups (p<0.05). Among the rats fed the cholesterol-enriched diet, all groups fed red yeast rice showed higher concentration of the HDL cholesterol, but lower concentration of the LDL cholesterol than those of the chol-control group. The scavenging activity of the methanol extract from red yeast rice was increased with increasing amounts of the extract. The glutathione content in the normal group and in the M-3 group were higher than that in the other groups. The M-3 group showed similar hepatic glutathione contents to those of the normal group. These results suggest that red yeast rice may be safe and effective for lowering serum levels of total and LDL-cholesterol, ratio of non-HDL/HDL, and severity of experimental atherosclerosis.
Keywords
red yeast rice; radical scavenging; antihypercholesterolemic effects;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Stuart MD. 1979. Chinese Materia Medica-vegetable kingdom. Southern Material Center, Inc., Taipei, China
2 Erdogrul O, Azirak S. 2004. Review of the studies on the red yeast rice (Monascus purpureus). Turkish Electronic J Biotechnol 2: 37-49
3 Lipid Research Clinics Program. 1984. The Lipid Research Clinics Coronary Primary Prevention Trial Results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251: 365-374   DOI
4 Buller N, Gillen D, Casciano R, Doyle J, Wilson K. 2003. A pharmacoeconomic evaluation of the myocardial ischaemia reduction with aggressive cholesterol lowering (MIRACL) study in the United Kingdom. Pharmacoeconomics 21(Suppl 1): 25-32   DOI
5 Su M, Wang X, Li Y, Gao Z. 1995. A clinical trial of Xuezhikang capsule in the treatment of hyperlipidemia. New Chin Herb Med Clin Pharmacol 6: 13-16
6 Zhao SP, Liu L, Cheng YC, Li YL. 2003. Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease. Atherosclerosis 168: 375-380   DOI   ScienceOn
7 Ma J, Li Y, Ye Q, Li J, Hua Y, Ju D, Zhang D, Cooper R, Chang M. 2000. Constituents of red yeast rice, a traditional Chinese food and medicine. J Agric Food Chem 48: 5220-5225   DOI   ScienceOn
8 Nielson LB, Stender S, Kjeldsen K. 1993. Effect of lovastatin on cholesterol absorption in cholesterolfed rabbits. Pharmacol Toxicol 72: 148-151
9 Tonolo G, Melis MG, Formato F, Angus MF, Carboni A, Brizzi P, Ciccarese M, Cherchi GM, Maioli M. 2000. Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients. Eur J Clin Invest 30: 980-987   DOI   ScienceOn
10 Zhir BQ, Sievers RE, Sum YP, Isenberg WM, Parmley WW. 1992. Effect of lovastatin on suppression of atherosclerosis in lipid fed rabbits. J Cardiovasc Pharmacol 19: 246-255   DOI
11 Li C, Zhu Y, Wang Y, Zhu J-S, Chang J, Kritchevsky D. 1998. Monascus purpureus-fermented rice (red yeast rice): a natural food product that lowers blood cholesterolin animal models of hypercholesterolemia. Nutr Res 18: 71-81   DOI   ScienceOn
12 Madhavi DL, Singhal RS, Kulkarni PR. 1996. Technological aspects of food antioxidants. In Food Antioxidants: Technological, Toxicological, and Health Perspectives. Madhavi DL, Deshpande SS, Salunkhe DK, eds. Marcel Dekker, New York. p 59-265
13 Yen GC, Duh PD, Tsai CL. 1993. The relationship between antioxidant activity and maturity of peanut hulls. J Agric Food Chem 41: 67-70   DOI
14 Bray TM, Taylor CG. 1993. Tissue glutathione, nutrition, and oxidative stress. Can J Physiol Pharm 71: 746-751   DOI   ScienceOn
15 Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC. 2000. Cost-effectiveness of cholesterol lowering therapies according to patient characteristics. Ann Intern Med 132: 769-774
16 Yang JH, Tseng YH, Lee YL, Mau JL. 2006. Antioxidant properties of methanolic extracts from monascal rice. LWT Food Sci Technol 39: 740-747   DOI   ScienceOn
17 Li C, Zhu Y, Wang Y, Zhu J, Chang J, Kritchevsky D. 1997. Monascus purpureus fermented (red yeast rice): A natural food product that lowers blood cholesterol in animal models of hypercholesterolemia. Nutr Res 18: 71-82   DOI   ScienceOn
18 Shen Z, Yu P, Sun M, Chi J, Zhou Y, Zhu X, Yang C, He C. 1996. Treatment of primary hyperlipidemia with Zhitai (Xuezhikang) capsule: A pilot clinical study. Natl Med J China 76: 156-157
19 Sparrow CP, Burton CA, Hernandez M, Mundt S, Hassing H, Patel S, Rosa R, Hermanowski-Yosetka A, Wang PR, Zhang D, Peterson L, Detmers PA, Chao Y-S, Wright SD. 2001. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol 21: 115-121   DOI   ScienceOn
20 Otto J, Ordovas JM, Smith D, van Dongen D, Nicolosi RJ, Schaefer EJ. 1995. Lovastatin inhibits diet induced atherosclerosis in FIB golden Syrian hamsters. Atherosclerosis 114: 19-28   DOI   ScienceOn
21 Ellman GL. 1959. Tissue sulfhydryl group. Arch Biochem Biophy 82: 70-74   DOI   ScienceOn
22 Schimada K, Fujikawa K, Yahara K, Nakamura T. 1992. Antioxidative properties of xanthan on the autoxidation of soybean oil in cyclodextrin emulsion. J Agric Food Chem 40: 945-948   DOI
23 Ohkawa H, Ohishi N, Yaki K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358   DOI   ScienceOn
24 Scandinavian Simvastatin Survival Study Group. 1994. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Survival Study (4S). Lancet 314: 1383-1389
25 Gaw A. 1996. Can the clinical efficacy of the HMG-CoA reductase inhibitors be explained solely by their effects on LDL-cholesterol? Atherosclerosis 125: 267-269   DOI   ScienceOn
26 Halliwell B, Murcia MA, Chirico S, Aruoma OI. 1995. Free radical and antioxidants in food and in vivo: What they do and how they work. Crit Rev Food Sci 35: 7-20   DOI   ScienceOn
27 Frick MH, Elo O, Haapa K. 1987. Helsinki Heart Study: primary prevention trial with gentibrozil in middle aged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317: 1237-1245   DOI   ScienceOn
28 Havel RJ. 1999. Dietary supplement or drug? The case of cholestin. Am J Clin Nutr 69: 175-176   DOI
29 Chang HL. 2001. Evaluation of taste quality, antioxidant properties and storage stability of monascal adlay. MS thesis. National Chung-Hsing University, Taichung, Taiwan